Additionally, recent studies have increasingly demonstrated the involvement of DCDC2 in the occurrence and development of various malignant tumors, including ovarian cancer, breast cancer, prostate cancer, colorectal cancer, and HCC27,49–52. This evidence concerns the gene DCDC2 and prostate carcinoma.